Research Progress of Cordyceps sinensis and Its Fermented Mycelium Products on Ameliorating Renal Fibrosis by Reducing Epithelial-to-Mesenchymal Transition-Reference-Cited by-同舟云学术

Research Progress of Cordyceps sinensis and Its Fermented Mycelium Products on Ameliorating Renal Fibrosis by Reducing Epithelial-to-Mesenchymal Transition

Published:2023-07 Issue: Volume:Volume 16 Page:2817-2830
ISSN:1178-7031
Container-title:Journal of Inflammation Research
language:en
Short-container-title:JIR

Author:

Zhang Yaling^ORCID,Li Kaiyun,Zhang Chao,Liao Hui^ORCID,Li Rongshan

Publisher

Informa UK Limited

Subject

Immunology,Immunology and Allergy

Reference91 articles.

1. Mechanisms of Renal Fibrosis

2. Treatment of Renal Fibrosis—Turning Challenges into Opportunities

3. Defining therapeutic targets for renal fibrosis: Exploiting the biology of pathogenesis

4. Cellular and molecular mechanisms in kidney fibrosis

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel glucomannan-like polysaccharide from Lycium barbarum L. ameliorates renal fibrosis via blocking macrophage-to-myofibroblasts transition;International Journal of Biological Macromolecules;2024-10

2. Exploring the mechanism of Corbrin capsules in the intervention of AKI-COVID-19 based on network pharmacology combined with GEO dataset;Gene;2024-07

3. Use of bailing capsules (cordyceps sinensis) in the treatment of chronic kidney disease: a meta-analysis and network pharmacology;Frontiers in Pharmacology;2024-04-05

4. Isolation and target identification of anti-renal fibrosis compounds from Cordyceps militaris;Bioorganic Chemistry;2024-03

5. Effect of the Combination of Clostridium butyricum and Mycelium of Phellinus igniarius on Intestinal Microbiota and Serum Metabolites in DSS-Induced Colitis;Nutrients;2024-01-02